Serial activation of the tyrosine kinases Lck and ZAP-70 initiates signaling downstream of the T cell receptor. We previously reported the structure of an autoinhibited ZAP-70 variant in which two regulatory tyrosine residues (315 and 319) in the SH2-kinase linker were replaced by phenylalanine. We now present a crystal structure of ZAP-70 in which Tyr 315 and Tyr 319 are not mutated, leading to the recognition of a five-residue sequence register error in the SH2-kinase linker of the original crystallographic model. The revised model identifies distinct roles for these two tyrosines. As seen in a recently reported structure of the related tyrosine kinase Syk, Tyr 315 of ZAP-70 is part of a hydrophobic interface between the regulatory apparatus and the kinase domain, and the integrity of this interface would be lost upon engagement of doubly phosphorylated peptides by the SH2 domains. Tyr 319 is not necessarily dislodged by SH2 engagement, which activates ZAP-70 only ϳ5-fold in vitro. In contrast, phosphorylation by Lck activates ZAP-70 ϳ100-fold. This difference is due to the ability of Tyr 319 to suppress ZAP-70 activity even when the SH2 domains are dislodged from the kinase domain, providing stringent control of ZAP-70 activity downstream of Lck.
Signaling by the T cell receptor (TCR) relies on two nonreceptor tyrosine kinases: the Src family tyrosine kinase Lck and the zeta-chain-associated protein kinase ZAP-70 ( Fig. 1) (1). The clustering of coreceptor (CD4 or CD8)-associated Lck with T cell receptors allows Lck to phosphorylate tyrosine residues in immunoreceptor tyrosine-based activation motifs (ITAMs) in the intracellular tails of zeta chains of the TCR complex. Doubly phosphorylated ITAMs in the stimulated TCR complex recruit ZAP-70 to the plasma membrane, where it is phosphorylated by Lck (2, 3). ITAM binding and phosphorylation release ZAP-70 from an autoinhibited state, enabling it to phosphorylate two scaffold proteins, LAT (linker for the activation of T cells) and SLP-76 (Src homology 2 domain-containing leukocyte phosphoprotein of 76 kDa), leading to the recruitment of effector proteins that stimulate T cell activation (4, 5).TCR signaling events in a Jurkat-derived ZAP-70-deficient cell line are completely abolished. Hypomorphic ZAP-70 mutant mice, which have partial defects in TCR signaling, develop autoimmunity or autoimmune disease (6-8). The importance of ZAP-70 for T cell development and activation is further emphasized by the fact that the loss of ZAP-70 function results in severe combined immunodeficiency (SCID) in both humans and mice, which is characterized by a lack of functional peripheral T cells (9-12). The tight association of these diseases with ZAP-70 catalytic activity indicates clearly that ZAP-70 is a potential therapeutic target.ZAP-70 and its close relative Syk, which is essential for B cell receptor signaling, share a domain architecture that is unique among protein kinases. The N-terminal half of each protein contains two SH2 domains that form a tightly coupled module in...